322 related articles for article (PubMed ID: 16129514)
1. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
[TBL] [Abstract][Full Text] [Related]
2. Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease.
Tsang SW; Pomakian J; Marshall GA; Vinters HV; Cummings JL; Chen CP; Wong PT; Lai MK
Neurobiol Aging; 2007 Sep; 28(9):1381-7. PubMed ID: 16828202
[TBL] [Abstract][Full Text] [Related]
3. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
Flynn DD; Weinstein DA; Mash DC
Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
[TBL] [Abstract][Full Text] [Related]
4. Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
Lai MK; Tsang SW; Garcia-Alloza M; Minger SL; Nicoll JA; Esiri MM; Wong PT; Chen CP; Ramírez MJ; Francis PT
Neurobiol Dis; 2006 Jun; 22(3):555-61. PubMed ID: 16473016
[TBL] [Abstract][Full Text] [Related]
5. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
Muma NA; Mariyappa R; Williams K; Lee JM
Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374
[TBL] [Abstract][Full Text] [Related]
6. Spatial memory in aged rats is related to PKCgamma-dependent G-protein coupling of the M1 receptor.
Rossi MA; Mash DC; deToledo-Morrell L
Neurobiol Aging; 2005 Jan; 26(1):53-68. PubMed ID: 15585346
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease.
Rodríguez-Puertas R; Pascual J; Vilaró T; Pazos A
Synapse; 1997 Aug; 26(4):341-50. PubMed ID: 9215593
[TBL] [Abstract][Full Text] [Related]
8. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease.
Shiozaki K; Iseki E
J Neurol Sci; 2004 Aug; 223(2):145-8. PubMed ID: 15337615
[TBL] [Abstract][Full Text] [Related]
9. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group.
DeKosky ST; Harbaugh RE; Schmitt FA; Bakay RA; Chui HC; Knopman DS; Reeder TM; Shetter AG; Senter HJ; Markesbery WR
Ann Neurol; 1992 Nov; 32(5):625-32. PubMed ID: 1360195
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson's Disease Dementia.
Lee JH; Francis PT; Ballard CG; Aarsland D; Kalaria RN; Wong PT; Chen CP; Lai MK
J Parkinsons Dis; 2016 Oct; 6(4):733-739. PubMed ID: 27662332
[TBL] [Abstract][Full Text] [Related]
11. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies.
Ballard C; Piggott M; Johnson M; Cairns N; Perry R; McKeith I; Jaros E; O'Brien J; Holmes C; Perry E
Ann Neurol; 2000 Dec; 48(6):868-76. PubMed ID: 11117543
[TBL] [Abstract][Full Text] [Related]
12. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia.
Nordberg A; Alafuzoff I; Winblad B
J Neurosci Res; 1992 Jan; 31(1):103-11. PubMed ID: 1613816
[TBL] [Abstract][Full Text] [Related]
14. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
[TBL] [Abstract][Full Text] [Related]
15. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
Aisa B; Gil-Bea FJ; Solas M; García-Alloza M; Chen CP; Lai MK; Francis PT; Ramírez MJ
J Alzheimers Dis; 2010; 20(2):659-68. PubMed ID: 20164549
[TBL] [Abstract][Full Text] [Related]
16. Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease.
Ikonomovic MD; Abrahamson EE; Isanski BA; Wuu J; Mufson EJ; DeKosky ST
Arch Neurol; 2007 Sep; 64(9):1312-7. PubMed ID: 17846271
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.
Garcia-Alloza M; Gil-Bea FJ; Diez-Ariza M; Chen CP; Francis PT; Lasheras B; Ramirez MJ
Neuropsychologia; 2005; 43(3):442-9. PubMed ID: 15707619
[TBL] [Abstract][Full Text] [Related]
18. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
Albasanz JL; Dalfó E; Ferrer I; Martín M
Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
[TBL] [Abstract][Full Text] [Related]
19. Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease.
Ikonomovic MD; Mufson EJ; Wuu J; Bennett DA; DeKosky ST
Arch Neurol; 2005 Mar; 62(3):425-30. PubMed ID: 15767507
[TBL] [Abstract][Full Text] [Related]
20. Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease.
Potter PE; Rauschkolb PK; Pandya Y; Sue LI; Sabbagh MN; Walker DG; Beach TG
Acta Neuropathol; 2011 Jul; 122(1):49-60. PubMed ID: 21533854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
